Standard Motion · S2M-05218 · Session 2
Relief from Early Stages of Alzheimer's
The motion
That the Parliament notes with regret the decision of the National Institute of Health and Clinical Excellence not to recommend that drugs such as Aricept, used to treat Alzheimer’s disease, are made available for wider use, and calls on the Scottish Executive and NHS Quality Improvement Scotland not to subscribe to this decision which would restrict access to drugs that have been shown to slow the effects of Alzheimer’s disease in its early stages.
Signatures by party
27 MSPs besides the lodger · 15 from other partiesParty on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions
Vote
No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.
Supporters
27 MSPsSNP 12 Green 4 SSP 3 Con 2 Ind 2 LD 2 Sol 1 SSCUP 1
Show all 27 supporters by party
SNP 12
- Brian Adam
- Bruce Crawford
- Linda Fabiani
- Rob Gibson
- Christine Grahame
- Adam Ingram
- Alex Neil
- Stewart Stevenson
- John Swinney
- Maureen Watt
- Andrew Welsh
- Sandra White
Green 4
SSP 3
Con 2
Ind 2
LD 2
Sol 1
SSCUP 1
Party shown is each supporter’s party when the motion was published.
In the Official Report
No contribution in the Official Report cites S2M-05218 by reference.